So Far This Year, GSK plc (GSK) Reached A New High 5 times


As of Wednesday close, GSK plc’s (NYSE:GSK) stock was down -$0.16, moving down -0.47 percent to $33.69. The average number of shares traded per day over the past five days has been 3,669,340 shares. 5 times new highs have been achieved over the past 5 days, with a $0.78 gain in that time frame. In the last twenty days, the average volume was 6,160,485, while in the previous 50 days, it was 6,392,050.

Since last month, GSK stock rose 4.50%. Shares of the company fell to $31.22 on 11/11/22, the lowest level in the past month. A 52-week high of $47.82 was reached on 04/11/22 after having rallying from a 52-week low of $28.47. Since the beginning of this year, GSK’s stock price has dropped by -24.96% or -$10.41, and marked a new high 9 times. However, the stock has declined by -29.54% since its 52-week high.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Valuation Metrics

Right now, GSK plc (GSK) has a P/E ratio of about 14.32. The stock’s beta is 0.70. Besides these, the trailing price-to-sales (P/S) ratio of 1.80, the price-to-book (PB) ratio of 6.34, and the price-to-cash flow ratio of 13.49 may also be considered.

The latest dividend of $0.3695 per share was paid out, which is -3.52% less than last year’s $0.3830. On Wednesday November 2 2022, a $0.0135 dividend decrease was announced.

Financial Health

In the three months ended June 29, GSK plc’s quick ratio stood at 0.70, while its current ratio was 1.00, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 2.11, and the total debt-to-equity ratio was 2.42. On the profitability front, the trailing twelve-month gross margin is 65.40% percent. In the year ended June 29, operating margins totaled 17.30%. Based on annual data, GSK earned $30.95 billion in gross profit and brought in $46.91 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 14.80%. Return on equity (ROE) for the past 12 months was 96.60%.

In GSK plc’s quarter-end financial report for June 29, it reported total debt of -$921.0 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. GSK’s revenue rose 0.04% during the quarter, while net income inched up to $34.11 billion. While analysts expected GSK plc to report $0.73 quarterly earnings, the actual figure was $0.87 per share, beating the consensus estimate by 19.20%. During the quarter, the company generated $2.43 billion in EBITDA. The liabilities of GSK plc were 60.77 billion at the end of its most recent quarter ended June 29, and its total debt was $22.11 billion.

Technical Picture

This quick technical analysis looks at GSK plc’s (GSK) price momentum. With a historical volatility rate of 38.58%, the RSI 9-day stood at 61.32% on 23 November.

With respect to its five-day moving average, the current GSK plc price is up by +2.37% percent or $0.78. At present, GSK shares trade +3.06% above its 20-day simple moving average and -22.19% percent below its 100-day simple moving average. However, the stock is currently trading approximately +7.98% above its SMA50 and -25.50% below its SMA200.

Stochastic coefficient K was 89.98% and Stochastic coefficient D was 76.36%, while ATR was 0.74. Given the Stochastic reading of 93.24% for the 14-day period, the RSI (14) reading has been calculated as 59.39%. As of today, the MACD Oscillator reading stands at 0.80, while the 14-day reading stands at 0.89.

Analyst Ratings

GSK plc downgraded its rating on GSK plc (NYSE: GSK) to a Sell in a note to investors on November 11, 2022. The analysts firm previously had a Neutral rating on the stock.GSK plc (GSK) has been rated Overweight by analysts. According to 1 brokerage firm, GSK is a sell, and 13 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate GSK plc stock as buy, with 7 recommending it as overweight.

With a median target price of $38.19, the current consensus forecast for the stock is $30.37 – $60.03. Based on these forecasts, analysts predict GSK plc (GSK) will achieve an average price target of $39.24.


Please enter your comment!
Please enter your name here